The new facility will enable production of 25 million more patient doses per year of contrast media by the end of 2027.

The update comes about six weeks after an early alert flagged reports of 120 injuries and one death linked to reprocessing of ...

CEO Scott Whitaker said “an exemption was provided for most medical devices during President Trump’s first term with respect ...

Brent Shafer, Baxter’s lead independent director, will serve as interim CEO. The company also promoted Heather Knight to chief operating officer.